{{Rsnum
|rsid=35605
|Gene=ABCC1
|Chromosome=16
|position=16068162
|Orientation=plus
|GMAF=0.1809
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABCC1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 67.3 | 31.0 | 1.8
| HCB | 59.9 | 34.3 | 5.8
| JPT | 55.9 | 41.4 | 2.7
| YRI | 81.6 | 18.4 | 0.0
| ASW | 73.7 | 24.6 | 1.8
| CHB | 59.9 | 34.3 | 5.8
| CHD | 60.6 | 35.8 | 3.7
| GIH | 42.0 | 41.0 | 17.0
| LWK | 84.4 | 15.6 | 0.0
| MEX | 51.7 | 44.8 | 3.4
| MKK | 69.2 | 30.8 | 0.0
| TSI | 64.7 | 30.4 | 4.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs35605
|Name_s=ABCC1: 1684C>T
|Gene_s=ABCC1
|Feature=Exon/Syn
|Evidence=PubMed ID:19940846
|Annotation=The AUCs of irinotecan, SN-38, SN-38 glucuronide, and APC are influenced by rs3740066, rs2306283, rs35605, rs10276036, and rs717620 .
|Drugs=irinotecan; SN-38
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111618
}}

{{PMID Auto
|PMID=16684361
|Title=Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs35605
|overall_frequency_n=8886
|overall_frequency_d=10478
|overall_frequency=0.848063
|n_genomes=47
|n_genomes_annotated=0
|n_haplomes=78
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}